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An increase in creatinine >3mol/L/h has been suggested to predict death in patients with paraquat
self-poisoning and the value of other plasma biomarkers of acute kidney injury has not been assessed.
The aim of this study was to validate the predictive value of serial creatinine concentrations and to study
the utility of cystatin C and neutrophil gelatinase-associated lipocalin (NGAL) as predictors of outcome in
patients with acute paraquat poisoning. The rate of change of creatinine (dCr/dt) and cystatin C (dCyC/dt)
concentrations were compared between survivors and deaths. Receiver-operating characteristic (ROC)araquat
rognosis
idney injury
uman
reatinine
iomarker
curves were constructed to determine the best threshold for predicting death. Paraquat was detected in
20 patients and 7 of these died between 18h and 20 days post-ingestion. The dCr/dt ROC curve had an
area of 0.93 and the cut-off was >4.3mol/L/h (sensitivity 100%, speciﬁcity 85%, likelihood ratio 7). The
dCyC/dt ROC curve had an area of 0.97 and the cutoff was >0.009mg/L/h (sensitivity 100%, speciﬁcity
91%, likelihood ratio 11). NGAL did not separate survivors from deaths. Death due to acute paraquat
ith c
eededystatin C
GAL
poisoning is associated w
these measurements is n
. Introduction
Paraquat (1,1′-dimethyl-4,4′-bipyridinium) dichloride is a non-
elective contact herbicide widely used in many countries since
he 1960s. It is an important cause of fatal self-poisoning in some
ountries, particularly in South-East Asia (Gunnell et al., 2007).
he outcome of paraquat poisoning is variable but in large cohort
tudies typically between 40 and 60% of cases die, most within
4–72h from multi-organ failure (Dawson et al., 2010; Gil et al.,
008; Senarathna et al., 2009). However, patients with smaller
xposures may die over the following weeks from respiratory fail-
re secondary to progressive pulmonary ﬁbrosis. Better prognostic
ndicators to identify this group would be very useful as ongo-
ng interventions are most likely to be beneﬁcial for this group
∗ Corresponding author at: Department of Clinical Pharmacology and Toxicology,
t. Vincent’s Hospital, Victoria Street, Darlinghurst, NSW 2010, Australia.
el.: +61 416 088 397; fax: +61 8382 2724.
E-mail address: 1darren1@gmail.com (D.M. Roberts).
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Open access under CC BY license.hanges in creatinine and cystatin concentrations. Further validation of
before they can be adopted in guiding intensive treatments.
© 2011 Elsevier Ireland Ltd. 
withdelayed toxicity. Paraquatproduces free radicalswhich induce
cellular toxicity (Eddleston et al., 2003). Many treatments have
been proposed and trialled, including extracorporeal elimination,
immunosuppressants and antioxidants, but the mortality remains
high even in centres using all these treatments (Gil et al., 2008) (and
JL Lin, unpublished observation 2010).
A very strongpredictor of death in large cohort studies is the vol-
ume of paraquat consumed (Wilks et al., 2008, 2011), but estimates
of this are often unreliable in individual patients. The concentra-
tion of paraquat in blood or urine can be used as a surrogate for
ingested dose to predict survival or death using a nomogram. These
have a positive predictive value for death of 92–96% (Senarathna
et al., 2009). Unfortunately paraquat assays are not widely avail-
able, particularly in the developingworld, and the time of ingestion
may be unknown, so alternative biomarkers are required which
Open access under CC BY license.should ideally be able to be interpreted independent of the time of
exposure.
A range of alternative clinical and biochemical investigations for
prognosis following acute paraquat poisoning have been assessed,
but inadequately validated (Eddleston et al., 2003). For example,
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cute kidney injury is a prominentmanifestation of acute paraquat
oisoning which has prompted research into renal biomarkers (Gil
t al., 2009; Ragoucy-Sengler and Pileire, 1996). One small study
n=18) suggested that an increase in creatinine of >3mol/L/h
dCr/dt) predicts death (Ragoucy-Sengler and Pileire, 1996). The
ise in creatinine is probably due to progressive renal impairment
ndadirect reﬂectionof organ toxicity (Pondet al., 1993).However,
araquat interferes with some creatinine assays that utilise the
affe (picric-acid)method (Aitken et al., 1994; Fairshter et al., 1986;
rice et al., 1995; Webb and Davies, 1981). Therefore, the increase
n creatinine may reﬂect both exposure and toxicity. The appar-
nt creatinine concentration increases with increasing paraquat
oncentrations (Aitken et al., 1994; Fairshter et al., 1986; Price
t al., 1995; Webb and Davies, 1981), although minimally with
oncentrations less than 10mg/L, in contrast to concentrations
reater than 100mg/L where interference is marked (Fairshter
t al., 1986;Webb and Davies, 1981). In clinical practice themajor-
ty of paraquat concentrations are less than 100mg/L (Senarathna
t al., 2009).
The predictive value of other plasma biomarkers of acute kid-
ey injury, such as cystatin C or neutrophil gelatinase-associated
ipocalin (NGAL), have not been assessed in acute paraquat poison-
ng. A single studynoted that urinaryNGAL correlatedwith changes
n creatinine concentration in patientswith acute kidney injury (Gil
t al., 2009).
The objective of this study was to further explore the util-
ty of serial creatinine concentrations for predicting death and to
xamine the utility of plasma cystatin C and NGAL as alternative
redictive biomarkers.
. Materials and methods
This studywas approved byHumanResearch Ethics Committees in Australia, Sri
anka and UK. We prospectively identiﬁed all patients with acute paraquat expo-
ure presenting to Anuradhapura and PolonnaruwaHospitals in Sri Lanka. These are
egional referral hospitals that provide 24-hmedical and nursing care to patients in
edicated medical wards. Patients were directly admitted to a medical ward or via
ransfer from a remote hospital where they were medically assessed.
Every patient presenting to these study hospitals with a history of an acute
araquat exposure was reviewed by on-site study doctors. Following an initial clin-
cal assessment and resuscitation, the history of exposure (including co-ingestants)
as obtained on presentation for each patient. All patients received supportive
are, including intravenous ﬂuids and ventilatory and haemodynamic support as
equired; oxygen supplementation is withheld in patients with paraquat poisoning
nless treatment is palliative and the patient is hypoxic. Patients were followed by
edicated study doctors until discharge or death. Follow up visits to the patient’s
ome were attempted approximately 6 months after discharge to conﬁrm survival.
Written informed consent was provided by 26 patients between 23rd April
005 and 3rd September 2006 for the collection of additional blood samples. Blood
amples were obtained at least 4h post-ingestion (well after the peak plasma con-
entration), immediately centrifuged and plasmawas taken off and stored at−23 ◦C
ntil analysis. Samples were shipped to the UK to quantify the concentration of
araquat, creatinine and cystatin C. Available duplicate samples were shipped to
ustralia to quantify the concentration of NGAL.
Paraquat and creatinine analyses were conducted by Syngenta CTL (Alderley
ark, Macclesﬁeld, Cheshire, UK) in October 2006. The paraquat concentration was
easured usingHPLC, LC–MS–MS, and LC ﬂuorescence (Blake et al., 2002). The crea-
inine concentrationwasmeasured utilising themodiﬁed Jaffe (picric-acid)method
ccording to product guidelines (Labmedics, UK).
The cystatin C concentration was measured by Chemical Pathology, St. Thomas’
ospital, London, UK in April 2007. This utilised a particle-enhanced nephelometric
ssay on a Dade Behring BNII nephlometer (Milton Keynes, UK) with antisera and
alibrators supplied by Dade Behring (Bandaranayake et al., 2007).
NGAL concentrationwasmeasured by Therapeutics Research Centre, University
f Queensland, Brisbane, Australia in October 2009. These assays were conducted
sing the Triage® NGAL Test, a point-of-care ﬂuorescence immunoassay using the
riage Meter according to product guidelines.. Calculation
Median values and inter-quartile ranges were determined for
ach renal biomarker and compared non-parametrically. The rateetters 202 (2011) 69–74
of change of creatinine and cystatin C concentrations in serial sam-
plesweredeterminedandcomparedbetweensurvivorsanddeaths.
Receiver-operating characteristic (ROC) curves were constructed
to determine the best threshold (as determined by Youden’s index
(Youden, 1950)) for the rate of change of creatinine (dCr/dt) and
cystatin C (dCyC/dt) concentrations for predicting death, includ-
ing likelihood ratios, sensitivities and speciﬁcities. Sensitivity is
the proportion of all deaths that were predicted to die by the
test (cut-off), speciﬁcity is the proportion of survivors predicted
to survive by the test. All analyses were conducted using GraphPad
Prism version 4.03 for Windows, GraphPad Software, San Diego,
USA, www.graphpad.com and P<0.05 was considered statistically
signiﬁcant. Prediction of outcome on the basis of the admission
paraquat concentration was determined according to Senarathna
et al. (2009).
4. Results
4.1. Clinical outcomes
Paraquat exposure was conﬁrmed in 20 patients who were eli-
gible for inclusion; the other 6 patients were excluded. 14 of the 16
patients who were discharged alive were followed up in the com-
munity and three of these patients subsequently died. Altogether,
seven patients died at 18h, 48h, 65h, 11 days, 12 days, 15 days and
20 days after exposure. On the basis of the admission paraquat con-
centration, all actual deaths were predicted to die according to the
Proudfoot nomogram (Eddleston et al., 2003). A total of 86 blood
samples fromdifferent time pointswere assayed, although in some
cases the volume was too small for every test to be conducted.
4.2. Changes in biomarkers of acute kidney injury post-admission
Serial concentrations of creatinine and cystatin C for individuals
are shown in Fig. 1a and b, respectively. In the case of creatinine
and cystatin C, increasing concentrations during the ﬁrst 24–48h
were observed which were suitable for further analyses. Because
biochemical data from patients who died were unavailable beyond
75h post-ingestion, all subsequent analyses in surviving patients
were limited to data obtained within the same period.
The plasma concentration of NGALwasmeasured in 14 patients
and serial changes are shown in Fig. 1c. No relationship was
observed that could be used to separate survivors from the four
deaths captured in this study (which occurred 48h, 65h, 11 days
and 12 days post-ingestion). Of these deaths, NGAL was not ele-
vated in one patient while in the other three patients the highest
concentration was 331ng/mL and most were less than 100ng/mL.
The NGAL plasma concentration in one survivor was as high as
608ng/mL.
4.3. Temporal trends in biomarkers of acute kidney injury
Where multiple samples were available in a single patient, in
many cases the rates of increase in creatinine and cystatin C con-
centrationswere approximately linear for the deaths (Fig. 1a and b)
and the overall rate of change (estimated by linear regression of all
samples)was used to construct ROC curves. The dCr/dt and dCyC/dt
in survivors were also estimated using linear regression for direct
comparison to data from survivors.
Of the 13 survivors, only four were found to have a positive
gradient for dCr/dt that was statistically different to zero (data
not shown). The gradients were much higher for deaths [medians
9.0mol/L/h (IQR 5.3–14.8) for deaths and 0.3mol/L/h (IQR −0.3
to 3.3) for survivors; P=0.002,Mann–Whitney test]. The ROC curve
had an area of 0.93 (95% CI 0.83–1.04). The best dCr/dt cut-off was
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cig. 1. (a) Serial plasma creatinine concentrations in patients with acute paraquat p
cute paraquat poisoning, relative to outcome. (c) Serial plasma NGAL concentrati
eference range (<60ng/mL) are plotted at 30ng/mL for illustrative purposes. (
4.3mol/L/h (sensitivity 100%, speciﬁcity 85% and likelihood ratio
) (Fig. 2a).
Of the 11 survivors for which dCyC/dt results were available,
nly one trend line was found to have a positive gradient and to be
tatistically different to zero (data not shown). The gradients were
gain statistically greater for deaths [median 0.049mg/L/h (IQR
.017–0.074) for deaths and 0.004mg/L/h (IQR −0.004 to 0.005)
or survivors; P=0.0022, Mann–Whitney test]. The dCyC/dt ROC
urve had an area of 0.97 (95% CI 0.90–1.04) and the best cutoff
as determined to be >0.009mg/L/h (sensitivity 100%, speciﬁcity
1% and likelihood ratio 11) (Fig. 2b).
In one of these patients the dCr/dt and dCyC/dt exceeded values
oted in deaths (Fig. 1a) and the creatinine concentration fulﬁll cri-
eria for acute renal failure. This patient was not predicted to die
ccording to the admission paraquat concentration. This patient
urvived tohospitaldischargewithout receivinghaemodialysis, but
as lost to follow up so it is not known whether death occurred
ater. Excluding the two patients discharged alive but unable to
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ig. 2. (a) Receiver-operator characteristic curve of dCr/dt for predicting death using line
urve of dCyC/dt for predicting death using linear regression data within 75h of poisoninng, relative to outcome. (b) Serial plasma cystatin C concentrations in patients with
patients with acute paraquat poisoning, relative to outcome. Values less than the
Reference range; ( ) death; ( ) alive.
be found at follow-up (creatinine data available for both patients
but cystatin C data only available in one) improved the predictive
value of creatinine but did not substantially alter the results of
this analysis for cystatin C. Speciﬁcally, dCr/dt ROC AUC=0.96 (95%
CI 0.87–1.05); best cutoff >4.3mg/L/h (sensitivity 100%, speciﬁcity
91% and likelihood ratio 11), and dCyC/dt ROC AUC=0.97 (95% CI
0.89–1.05); best cutoff >0.009mg/L/h (sensitivity 100%, speciﬁcity
90% and likelihood ratio 10.
However, as noted in Fig. 1a and b, the concentration of cre-
atinine and cystatin C did not increase (or decrease) consistently
in every patient. Therefore, dCr/dt and dCyC/dt values as deter-
mined by linear regression could vary depending on the time of
sampling. To evaluate the minimum duration of sampling post-
admission for assessing the dCr/dt or dCyC/dt, the rates of change
from the time of admission to each subsequent blood sample
for an individual patient were determined. Post-admission, on
the basis of the available data, sampling after a minimum of
approximately 12h appeared necessary to predict death for dCr/dt,
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mig. 3. (a) Inﬂuence of the time of the second sample on the estimated rate of chang
raph) in patients who died. Arrow depicts the last value below the cut-off threshol
ate of change of the concentration of creatinine (dCr/dt, upper graph) and cystatin
ompared to approximately 6h for dCyC/dt (Fig. 3a). However,
he relationship was less precise for survivors (Fig. 3b), con-
istent with the test being sensitive for death but not speciﬁc
Fig. 3b).
.4. Illustrative, data-rich cases
Serial changes in creatinine and cystatin C plasma concen-
rations with time in three of the six deaths, relative to the
oncentration of paraquat, are shown in Fig. 4. The rates of change
f creatinine and cystatin C are consistent with the results shown
n Fig. 2a and b. Some patients had acute renal impairment on
dmission on the basis of creatinine and cystatin C concentrations,
owever thesedeclined soonafter admissionwhichmaybedue to a
omponent of hypovolaemia. In one patient (P4656, Fig. 4), the cys-
atinCconcentration increased toaplateauwhile the concentration
f creatinine continued to increase.
.5. Potential for interference by paraquat with the creatinine
ssay
Since the highest plasma paraquat concentration in this cohort
as less than 10mg/L, this was considered insufﬁcient to inter-
ere with the creatinine assay on the basis of laboratory data
iscussedpreviously. Therefore, no further analysiswas conducted.
s shown in Fig. 5, the rates of change in creatinine concentra-
ion correlated well with those of cystatin C. This is consistent
ith both measurements demonstrating progressive renal impair-
ent.he concentration of creatinine (dCr/dt, upper graph) and cystatin C (dCyC/dt, lower
rmined by the ROC. (b) Inﬂuence of the time of the second sample on the estimated
yC/dt, lower graph) in patients who survived.
5. Discussion
This small study conﬁrms a previous report (Ragoucy-Sengler
and Pileire, 1996) suggesting that the rate of change in creatinine
concentration may be useful for predicting death after paraquat
poisoning. Further, we demonstrated that the rise in cystatin C (but
not NGAL) is also useful in predicting patients who may die. Due
to the relatively low concentrations of paraquat observed in these
patients it is unlikely that paraquat interfered with the creatinine
assay However, even if there is direct interference this should not
lead to rising concentrations of creatinine because the paraquat
concentrations will be falling.
It is generally considered that paraquat poisoned patients most
likely to beneﬁt from antidotes or other treatments are those
who will survive the ﬁrst 48h (Eddleston et al., 2003). As dis-
cussedpreviously, nomogramsutilising theparaquat concentration
can indicate the likelihood of death, but they do not differentiate
between early and late deaths. Sawada et al. developed a nomo-
gram using data from 30 patients which separated survivors, death
by ‘circulatory failure’ and death by ‘respiratory failure’, but the
time to death for each group was not stated (Sawada et al., 1988).
Moreover, laboratories that measure paraquat concentrations are
rare so alternative methods for risk stratiﬁcation are required.
Paraquat induces acute tubular necrosis due to direct toxicity
to the proximal tubule in particular, and to a lesser degree dis-
tal structures. Other factors inﬂuencing the development of acute
kidney injury include hypoperfusion from hypovolaemia and/or
hypotension and direct glomerular injury (Chan et al., 1998). Acute
kidney injury and failure is diagnosed on the basis of changes in
plasma creatinine concentration or urine output. In acute paraquat
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probably reﬂects the requirement for consent to obtain serial bloodatients with fatal outcome. The mean rates of change of creatinine and cystatin
concentrations in each individual are shown, (––) Paraquat; (––) creatinine;
··©··) cystatin C.
oisoning, creatinine peaks around ﬁve days post-ingestion and
esolves within three weeks in survivors (Kim et al., 2009). In con-
rast to a previous study where acute renal failure was not noted
n some patients who died (Gil et al., 2009), acute renal failure
as noted in all deaths in our study (Fig. 3a); it also occurred in
ne survivor (Fig. 1a). Further, our study noted that dCr/dt pre-
icts death where the best determinant was a rise >4.3mol/L/h
Fig. 2a), which is slightly higher than a rise >3mol/L/h in the
revious study (Ragoucy-Sengler and Pileire, 1996). These rates of
hange in creatinine are likely to represent a loss of at least 70–80%
f GFR (Waikar and Bonventre, 2009). At least 6–12h need to lapse
etween samples to ensure that minor variation due to analytical
rror and rehydration does not obscure the change.
A large number of biomarkers of acute kidney injury have beenescribed (Vaidya et al., 2008). Cystatin C is a 13kD protein that is
roduced by all nucleated cells. It is freely ﬁltered at the glomeru-
us, and in normally functioning renal tubules it is completely
atabolised and reabsorbed. In response to acute kidney injurydCr/dt (µmol/L/h)
Fig. 5. Relationship between dCr/dt and dCyC/dt in patients with acute paraquat
poisoning.
and/or inﬂammation there is an increase in concentration in both
plasma and urine (Vaidya et al., 2008). The concentration of cys-
tatin C is reported to increase prior to that of creatininewhen there
is a change in glomerular ﬁltration rate, although this may vary
between patient populations (Bagshaw and Bellomo, 2010). A sig-
niﬁcant increase in serum cystatin C concentration was observed
8h following acute paraquat poisoning in rats; at 24h an increase
was also detected in bronchoalveolar ﬂuid, however, it was sug-
gested that this was due to leakage from the serum (Hantson et al.,
2008a). A previous case report of acute paraquat poisoning also
noted an increase in cystatin C and creatinine, similar to our ﬁnd-
ings (Hantson et al., 2008b). Our study is the ﬁrst case series to
evaluate the rate of change in cystatin C from acute paraquat poi-
soning. In survivors, cystatin C was noted to increase and plateau
while creatinine continued to increase. This is likely to relate to
a shorter half-life of cystatin C and therefore time to steady state
compared to creatinine. In their patient (who died 92h after admis-
sion) Hantson et al. reported a progressive increase in cystatin C
concentrations until 70h post-admission (Hantson et al., 2008b).
However, this patient’s treatment regimen included haemodialy-
sis, which removes cystatin C from plasma (Mayeur et al., 2010),
thereby complicating interpretation of this data.
NGAL is a 25kD protein associated with neutrophils but is also
produced by injured epithelial and renal tubular cells. It is freely ﬁl-
tered at the glomerulus. In response to acute kidney injury and/or
inﬂammation there is an increase in concentration in both plasma
and urine (Vaidya et al., 2008). Plasma NGAL appears to have diag-
nostic and prognostic value in acute kidney injury from various
causes (Haase et al., 2009). However, in our study plasma NGAL
did not correlate with survival (Fig. 1c). Urinary NGAL concentra-
tions also appear inadequate as an early predictor of outcomewith
acuteparaquat poisoningbecause themain increasewas seen>48h
post-ingestion (Gil et al., 2009). Urinary kidney injury molecule-1
(KIM-1) may be a more sensitive marker of renal injury than crea-
tinine, however, in a small study it did not appear to be useful for
predicting death (Gil et al., 2009).
A limitation of this study is the small numbers of patients,whichsamples for the study. Patients with any signiﬁcant ingestion of
paraquat are generally told they have a grim prognosis by doc-
tors who work in the hospitals where these patients are recruited
(Roberts, unpublished observation). Therefore, it is not surprising
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any patients declined to participate to limit further discomfort
such as obtaining serial blood tests). Future studies offering new
reatments are likely to be the best setting for recruiting sufﬁcient
umbers to further examine prognostic tests. Also, future studies
hould ensure that all patients are followed up a number ofmonths
ost-discharge to ensure survival, compared to follow up of 90% of
atients in this study.
Another limitation of this study is the delay in time to analysis.
hile the blood sampleswere stored frozen at−23 ◦C, it is possible
hat some degradation of NGAL during freezingmay have occurred.
his was reported in urine stored at −20 ◦C (Haase et al., 2009), but
either urine nor plasma samples stored at −80 ◦C (Haase et al.,
009; Pedersen et al., 2010).
The biomarkers evaluated here do not differentiate between
arly and late deaths and therefore cannot identify patients who
re most likely to beneﬁt from treatment.
. Conclusion
The rate of increase in creatinine or cystatin C over the ﬁrst
4h may be useful for predicting outcomes in patients with acute
araquat poisoning. Prospective, larger cohort studies are required
o conﬁrm these ﬁndings and to more precisely determine the
rognostic utility of these tests. Such studies should focus on the
reatinine and cystatin C rise over the ﬁrst 12–24h. The notable
hort term random variation suggests measurements taken at
horter time intervals are more likely to be misleading. If prop-
rly validated, markers such as increases in creatinine or cystatin C
ay support clinical decisions on the ﬁrst day regarding whether
ultiple complex treatments should be initiated in such patients,
r if palliation is the priority. It may also be useful as part of the
nclusion criteria for studies of new treatments.
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